Cancer Research UK has decided to cut funding to its existing grants and institutes by up to 10%, as well as its national network of Centres by nearly 20% amid the Covid-19 pandemic crisis.
In an open letter to the researcher community, the charity said the cuts equate to £44m. The organisation funds around 50% of the cancer research in the UK.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Cancer Research UK research and innovation executive director Iain Foulkes said: “Covid-19 has left the whole world in uncharted waters. And the unprecedented measures to control the global COVID-19 pandemic have had a huge impact on both our researchers’ ability to carry on in the lab and on our ability to fundraise.
“Faced with a predicted loss of 20-25% of fundraising income, we are forced to look for savings across our current portfolio.”
